Qiu Simei, Liu Yunfeng, Li Quhuan
Institute of Biomechanics/School of Bioscience and Bioengineering, South China University of Technology, Guangzhou People's Republic of China.
Guangdong Provincial Engineering and Technology Research Center of Biopharmaceuticals, South China University of Technology, Guangzhou People's Republic of China.
R Soc Open Sci. 2021 Aug 18;8(8):210066. doi: 10.1098/rsos.210066. eCollection 2021 Aug.
Bruton's tyrosine kinase (BTK) plays a vital role in mature B-cell proliferation, development and function. Its inhibitors have gradually been applied for the treatment of many B-cell malignancies. However, because of treatment-associated drug resistance or low efficacy, it is urgent to develop new inhibitors and/or improve the efficacy of current inhibitors, where finding the intrinsic activation mechanism becomes the key to solve this problem. Here, we used BTK T474M mutation as a resistance model for inhibitors to study the mechanism of BTK activation and drug resistance by free molecular dynamics simulations. The results showed that the increase of kinase activity of T474M mutation is coming from the conformation change of the activation ring and ATP binding sites located in BTK N-terminus region. Specifically, the Thr mutation changed the structure of A-loop and stabilized the binding site of ATP, thus promoting the catalytic ability in the kinase domain. This localized dynamics-driven activation mechanism and resistance mechanism of BTK may provide new ideas for drug development in B-cell malignancies.
布鲁顿酪氨酸激酶(BTK)在成熟B细胞的增殖、发育和功能中起着至关重要的作用。其抑制剂已逐渐应用于多种B细胞恶性肿瘤的治疗。然而,由于治疗相关的耐药性或疗效不佳,迫切需要开发新的抑制剂和/或提高现有抑制剂的疗效,而找到内在激活机制成为解决这一问题的关键。在此,我们使用BTK T474M突变作为抑制剂的耐药模型,通过自由分子动力学模拟研究BTK激活和耐药的机制。结果表明,T474M突变激酶活性的增加源于位于BTK N端区域的激活环和ATP结合位点的构象变化。具体而言,苏氨酸突变改变了A环的结构并稳定了ATP的结合位点,从而促进了激酶结构域的催化能力。这种由局部动力学驱动的BTK激活机制和耐药机制可能为B细胞恶性肿瘤的药物开发提供新的思路。